Number of the records: 1
Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study
- 1.
SYSNO ASEP 0566276 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve SCOPUS Title Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study Author(s) Deissová, T. (CZ)
Cvanová, M. (CZ)
Kala, Z. (CZ)
Jirásková Zákostelská, Zuzana (MBU-M) ORCID
Dolina, J. (CZ)
Kunovský, L. (CZ)
Kroupa, R. (CZ)
Pavlovský, Z. (CZ)
Lipový, B. (CZ)
Daněk, Z. (CZ)
Izakovičová Hollá, L. (CZ)
Urban, O. (CZ)
Navrátil, V. (CZ)
Lischke, R. (CZ)
Harustiak, T. (CZ)
Grolich, T. (CZ)
Procházka, V. (CZ)
Slabý, O. (CZ)
Borilova Linhartova, P. (CZ)Article number 8790748 Source Title Disease Markers - ISSN 0278-0240
Roč. 2022, Aug 31 (2022)Number of pages 13 s. Language eng - English Country GB - United Kingdom Keywords epidermal growth factor ; polymorphisms ; gene expression ; reflux esophagitis ; barrett's esophagus ; esophageal adenocarcinoma Subject RIV EI - Biotechnology ; Bionics OECD category Medical biotechnology related ethics Research Infrastructure RECETOX RI - 90121 - Masarykova univerzita Method of publishing Open access Institutional support MBU-M - RVO:61388971 EID SCOPUS 85137712582 DOI 10.1155/2022/8790748 Annotation The epidermal growth factor (EGF) and its receptor (EGFR) gene-gene interactions were shown to increase the susceptibility to esophageal cancer. However, the role of the EGF/EGFR pathway in the development of gastroesophageal reflux disease (GERD) and its complications (reflux esophagitis (RE), Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC)) remains unclear. This association study is aimed at investigating functional EGF and EGFR gene polymorphisms, their mRNA expression in esophageal tissues, and EGF plasma levels in relation to RE, BE, and EAC development in the Central European population. 301 patients with RE/BE/EAC (cases) as well as 98 patients with nonerosive reflux disease (NERD) and 8 healthy individuals (controls) were genotyped for +61 A>G EGF (rs4444903) and +142285 G>A EGFR (rs2227983) polymorphisms using the TaqMan quantitative polymerase chain reaction (qPCR). In random subgroups, the EGF and EGFR mRNA expressions were analyzed by reverse transcription qPCR in esophageal tissue with and without endoscopically visible pathological changes, and the EGF plasma levels were determined by enzyme-linked immunosorbent assay. None of the genotyped SNPs nor EGF-EGFR genotype interactions were associated with RE, BE, or EAC development (p>0.05). Moreover, mRNA expression of neither EGF nor EGFR differed between samples of the esophageal tissue with and without endoscopically visible pathology (p>0.05) nor between samples from patients with different diagnoses, i.e., RE, BE, or EAC (p>0.05). Nevertheless, the lower EGF mRNA expression in carriers of combined genotypes AA +61 EGF (rs4444903) and GG +142285 EGFR (rs2227983, p<0.05) suggests a possible direct/indirect effect of EGF-EGFR gene interactions on EGF gene expression. In conclusion, EGF and EGFR gene variants and their mRNA/protein expression were not associated with RE, BE or EAC development in the Central European population. Workplace Institute of Microbiology Contact Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231 Year of Publishing 2023 Electronic address https://www.hindawi.com/journals/dm/2022/8790748/
Number of the records: 1